Literature DB >> 31897167

Redefining the T1 category of the 8th American Joint Committee on Cancer Staging System for intrahepatic cholangiocarcinoma: A SEER database analysis.

Yang Li1, Chuangang Tang2, Bingqing Zhao3, Fang Dong4.   

Abstract

The T1 tumor category is further divided into T1a (≤5 cm) and T1b (>5 cm) by tumor size in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for intrahepatic cholangiocarcinoma (ICC). The aim of the present study was to investigate the association between tumor size and prognosis in patients with T1 ICC. The data regarding patients with ICC was downloaded from the Surveillance, Epidemiology, and End Results database between January 2004 and December 2013, at the time of first diagnosis and entered into the database. Demographic and pathological characteristics of patients were analyzed using an independent t-test and χ2 test. Overall survival was evaluated using Kaplan-Meier analysis; the cut-off point for tumor size was determined using the X-tile software. A total of 407 patients with ICC were selected from the analysis, including 199 cases with stage IA and 208 cases with stage IB tumors. The independent prognostic factors for patients with stage IA ICC were age and surgery. Independent prognostic factors for patients with stage IB ICC included age, surgery (yes vs. no) and tumor size (5-7 vs. ≥7 cm). The optimal cut-off value for tumor size was determined to be ~7 cm using X-tile software. Tumor size with a cut-off value of 7 cm could stratify patients by risk better than a value of 5 cm [hazard ratio (HR), 1.775; 95% confidence interval (CI), 1.356-2.323 and; HR, 1.402; 95% CI, 1.078-1.824, respectively]. This suggests that the T1 tumor category should be subclassified into T1a and T1b with a cut-off of 7 cm rather than 5 cm. The next edition of the AJCC staging system may take the present evidence into consideration for improvement regarding the accurate staging of ICC.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  intrahepatic cholangiocarcinoma; overall survival; staging; tumor size

Year:  2019        PMID: 31897167      PMCID: PMC6924027          DOI: 10.3892/ol.2019.11096

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.

Authors:  Sarah B Fisher; Sameer H Patel; David A Kooby; Sharon Weber; Mark Bloomston; Clifford Cho; Ioannis Hatzaras; Carl Schmidt; Emily Winslow; Charles A Staley; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2012-05-22       Impact factor: 3.647

Review 2.  Intrahepatic cholangiocarcinoma.

Authors:  George A Poultsides; Andrew X Zhu; Michael A Choti; Timothy M Pawlik
Journal:  Surg Clin North Am       Date:  2010-08       Impact factor: 2.741

Review 3.  Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature.

Authors:  Murad Aljiffry; Alhawsawi Abdulelah; Mark Walsh; Kevork Peltekian; Ian Alwayn; Michele Molinari
Journal:  J Am Coll Surg       Date:  2008-10-31       Impact factor: 6.113

4.  The risk factors and prognostic factors of intrahepatic cholangiocarcinoma.

Authors:  Xi-Hsuan Lin; Jiing-Chyuan Luo
Journal:  J Chin Med Assoc       Date:  2017-01-12       Impact factor: 2.743

5.  Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma.

Authors:  Gaya Spolverato; Aslam Ejaz; Yuhree Kim; Georgios C Sotiropoulos; Andreas Pau; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Todd W Bauer; Dustin M Walters; Ryan Groeschl; T Clark Gamblin; Wallis Marsh; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

6.  The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.

Authors:  Paisit Bunsiripaiboon; Pattana Sornmayura; Chumpon Wilasrusmee; Panuwat Lertsithichai
Journal:  J Med Assoc Thai       Date:  2010-01

7.  Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.

Authors:  Yuhree Kim; Dimitrios P Moris; Xu-Feng Zhang; Fabio Bagante; Gaya Spolverato; Carl Schmidt; Mary Dilhoff; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2017-06-12       Impact factor: 3.454

8.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

Review 9.  Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates.

Authors:  Andrew J Lee; Yun Shin Chun
Journal:  Chin Clin Oncol       Date:  2018-07-12

10.  Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery.

Authors:  Yo-Ichi Yamashita; Ken Shirabe; Toru Beppu; Susumu Eguchi; Atsushi Nanashima; Masayuki Ohta; Shinichi Ueno; Kazuhiro Kondo; Kenji Kitahara; Masayuki Shiraishi; Yuko Takami; Tomoaki Noritomi; Kohji Okamoto; Yoshito Ogura; Hideo Baba; Hikaru Fujioka
Journal:  Ann Gastroenterol Surg       Date:  2017-07-20
View more
  1 in total

1.  Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis.

Authors:  YiPing Chen; ShanGeng Weng
Journal:  J Gastrointest Surg       Date:  2020-11-02       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.